The molecular and metabolic influence of long term agmatine consumption

Journal of Biological Chemistry

Volumn 289, Issue 14, 2014, Pages 9710-9729

  Nissim, Itzhak ^a,b   Horyn, Oksana ^a   Daikhin, Yevgeny ^a   Chen, Pan ^a   Li, Changhong ^a   Wehrli, Suzanne L ^a   Nissim, Ilana ^a   Yudkoff, Marc ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOCHEMISTRY; CARBOXYLATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; NUTRITION; TISSUE;

CALORIC RESTRICTION; CARNITINE BIOSYNTHESIS; DIET-INDUCED OBESITY; FATTY ACID OXIDATION; METABOLIC PROFILING; METABOLIC REACTIONS; PLAUSIBLE MECHANISMS; POTENTIAL BENEFITS;

METABOLISM;

ACYLCARNITINE; AGMATINE; CARBON 13; CARNITINE; CYCLIC AMP; NITROGEN 15; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SHORT CHAIN ACYLCARNITINE; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCONEOGENESIS; GLYCOLYSIS; LIPID DIET; MALE; METABOLOMICS; NITROGEN METABOLISM; NONHUMAN; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; THERMOGENESIS; TISSUE LEVEL; UREA CYCLE; WEIGHT REDUCTION;

ADENYLATE CYCLASE (ADENYLYL CYCLASE); CARBOHYDRATE METABOLISM; CARNITINE; CYCLIC AMP (CAMP); FATTY ACID OXIDATION; INSULIN RESISTANCE; LIVER; METABOLIC SYNDROME;

AGMATINE; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CARNITINE; CYCLIC AMP; DIETARY FATS; FATTY ACIDS; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; HUMANS; LIVER; MALE; METABOLOME; OBESITY; OXIDATION-REDUCTION; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 84898076199     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.544726     Document Type: Article

References (61)

1. Li, G., Regunathan, S., Barrow, C. J., Eshraghi, J., Cooper, R., and Reis, D. J. (1994) Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263, 966-969
2. Piletz, J. E., Aricioglu, F., Cheng, J. T., Fairbanks, C. A., Gilad, V. H., Hae-nisch, B., Halaris, A., Hong, S., Lee, J. E., Li, J., Liu, P., Molderings, G. J., Rodrigues, A. L., Satriano, J., Seong, G. J., Wilcox, G., Wu, N., and Gilad, G. M. (2013) Agmatine: clinical applications after 100 years in translation. DrugDiscov. Today 18, 880-893
3. Nissim, I., Daikhin, Y., Nissim, I., Luhovyy, B., Horyn, O., Wehrli, S. L., and Yudkoff, M. (2006) Agmatine stimulates hepatic fatty acid oxidation: a possible mechanism for up-regulation of ureagenesis. J. Biol. Chem. 281, 8486-8496
4. Jitrapakdee, S. (2012) Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis. Int. J. Biochem. Cell Biol. 44, 33-45
5. Leavens, K. F., Easton, R. M., Shulman, G. I., Previs, S. F., and Birnbaum, M. J. (2009) Akt2 is required for hepatic lipid accumulation in models of insulin resistance. CellMetab. 10, 405-418
6. Nissim, I., Horyn, O., Daikhin, Y., Nissim, I., Luhovyy, B., Phillips, P. C, and Yudkoff, M. (2006) Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Res. 66, 7824-7831
7. Fimia, G. M., and Sassone-Corsi, P. (2001) Cyclic AMP signalling. J. Cell Sci. 114, 1971-1972
8. Cheng, X., Ji, Z., Tsalkova, T., and Mei, F. (2008) Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim. Biophys. Sin. 40, 651-662
9. Taskén, K., and Aandahl, E. M. (2004) Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol. Rev. 84, 137-167
10. Sands, W. A., and Palmer, T. M. (2008) Regulating gene transcription in response to cyclic AMP elevation. Cell. Signal. 20, 460-466
11. Lazennec, G., Canaple, L., Saugy, D., and Wahli, W. (2000) Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol. Endocrinol. 14, 1962-1975
12. Burns, K. A., and Vanden Heuvel, J. P. (2007) Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta 1771, 952-960
13. Burkart, E. M., Sambandam, N, Han, X., Gross, R. W., Courtois, M., Gi-erasch, C. M., Shoghi, K., Welch, M. J., and Kelly, D. P. (2007) Nuclear receptors PPAR/3/S and PPARa direct distinct metabolic regulatory programs in the mouse heart. J. Clin. Investig 117, 3930-3939
14. Kelly, D. P. (2001) The pleiotropic nature of the vascular PPAR gene regulatory pathway. Circ. Res. 89, 935-937
15. Muoio, D. M., and Koves, T. R. (2007) Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1a: implications for metabolic disease. Appl. Physiol. Nutr. Metab. 32, 874-883
16. Gutgesell, A., Wen, G., König, B., Koch, A., Spielmann, J., Stangl, G. I., Eder, K., and Ringseis, R. (2009) Mouse carnitine-acylcarnitine translocase (CACT) is transcriptionally regulated by PPARa and PPARS in liver cells. Biochim. Biophys. Acta 1790, 1206-1216
17. Mandard, S., Müller, M., and Kersten, S. (2004) Peroxisome proliferator-activated receptor a target genes. Cell. Mol. Life Sci. 61, 393-416
18. van Vlies, N, Ferdinandusse, S., Turkenburg, M., Wanders, R. J., and Vaz, F. M. (2007) PPARa-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. Biochim. Biophys. Acta 1767, 1134-1142
19. Eder, K., and Ringseis, R. (2010) The role of peroxisome proliferator-activated receptor a in transcriptional regulation of novel organic cation transporters. Eur. J. Pharmacol. 628, 1-5
20. Noland, R. C, Koves, T. R., Seiler, S. E., Lum, H, Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., and Muoio, D. M. (2009) Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J. Biol. Chem. 284, 22840-22852
21. Muoio, D. M., Noland, R. C, Kovalik, J. P., Seiler, S. E., Davies, M. N, DeBalsi, K. L., Ilkayeva, O. R., Stevens, R. D., Kheterpal, I., Zhang, J., Covington, J. D., Bajpeyi, S., Ravussin, E., Kraus, W., Koves, T. R., and Mynatt, R. L. (2012) Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab. 15, 764-777
22. 13C isotopomer-based metabolo-mics. Biochem. J. 444, 537-551
23. van Vlies, N., Wanders, R. J., and Vaz, F. M. (2006) Measurement of carnitine biosynthesis enzyme activities by tandem mass spectrometry: differences between the mouse and the rat. Anal. Biochem. 354, 132-139
24. Strijbis, K., Vaz, F. M., and Distel, B. (2010) Enzymology of the carnitine biosynthesis pathway. IUBMB Life 62, 357-362
25. ter Veld, F., Mueller, M., Kramer, S., Haussmann, U., Herebian, D., Mayatepek, E., Laryea, M. D., Primassin, S., and Spiekerkoetter, U. (2009) A novel tandem mass spectrometry method for rapid confirmation of medium-and very long-chain acyl-CoA dehydrogenase deficiency in newborns. PLoS One 4, e6449
26. Nissim, I., Horyn, O., Nissim, I., Daikhin, Y., Caldovic, L., Barcelona, B., Cervera, J., Tuchman, M., and Yudkoff, M. (2011) Down-regulation of hepatic urea synthesis by oxypurines: xanthine and uric acid inhibit N-acetylglutamate synthase. J. Biol. Chem. 286, 22055-22068
27. 15N. J. Biol. Chem. 274, 28958-28965
28. Nissim, I., and Weinberg, J. M. (1996) Glycine attenuates maleate or ifos-famide induced Fanconi syndrome in rats. Kidney Int. 49, 684-695
29. Nomura, M., Beltrán, C, Darszon, A., and Vacquier, V. D. (2005) A soluble adenylyl cyclase from sea urchin spermatozoa. Gene 353, 231-238
30. Folch, J., Lees, M., and Sloane Stanley, G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497-509
31. Li, C, Liu, C, Nissim, I., Chen, J., Chen, P., Doliba, N., Zhang, T., Nissim, I., Daikhin, Y., Stokes, D., Yudkoff, M., Bennett, M. J., Stanley, C. A., Matschinsky, F. M., and Naji, A. (2013) Regulation of glucagon secretion in normal and diabetic human islets by/3-hydroxybutyrate and glycine. J. Biol. Chem. 288, 3938-3951
32. T method. Methods 25, 402-408
33. Yang, L., Kasumov, T., Kombu, R. S., Zhu, S.-H, Cendrowski, A. V., David, F., Anderson, V E., Kelleher, J. K., and Brunengraber, H. (2008) Metabo-lomic and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle: II. Heterogeneity of metabolite labeling pattern. J. Biol. Chem. 283, 21988-21996
34. Bastard, J. P., Maachi, M., Lagathu, C, Kim, M. J., Caron, M., Vidal, H, Capeau, J., and Feve, B. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17, 4-12
35. Wolf, G. (2009) Brown adipose tissue: the molecular mechanism of its formation. Nutr. Rev. 67, 167-171
36. Yonezawa, T., Kurata, R., Hosomichi, K., Kono, A., Kimura, M., and Inoko, H. (2009) Nutritional and hormonal regulation of uncoupling protein 2. IUBMBLife 61, 1123-1131
37. Robbins, D., and Zhao, Y. (2011) New aspects of mitochondrial uncoupling proteins (UCPs) and their roles in tumorigenesis. Int. J. Mol. Sci. 12, 5285-5293
38. Muoio, D. M., and Neufer, P. D. (2012) (2012) Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab. 15, 595-605
39. Sampey, B. P., Freemerman, A. J., Zhang, J., Kuan, P. F., Galanko, J. A., O'Connell, T. M., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., New-gard, C. B., Brauer, H. A., Troester, M. A., and Makowski, L. (2012) Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One 7, e38812
40. Makowski, L., Noland, R. C, Koves, T. R., Xing, W., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., and Muoio, D. M. (2009) Metabolic profiling of PPARa-/-mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEBJ. 23, 586-604
41. Ringseis, R., Pösel, S., Hirche, F., and Eder, K. (2007) Treatment with pharmacological peroxisome proliferator activated receptor a agonist clo-fibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. Pharmacol. Res. 56, 175-183
42. Lamhonwah, A. M., and Tein, I. (2006) Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem. Biophys. Res. Commun. 345, 1315-1325
43. Exton, J.H. (1987) Mechanisms of hormonal regulation of hepatic glucose metabolism. Diabetes Metab. Rev. 3, 163-183
44. Burgess, S. C, Leone, T. C, Wende, A. R., Croce, M. A., Chen, Z., Sherry, A. D., Malloy, C. R., and Finck, B. N. (2006) Diminished hepatic gluconeo-genesis via defects in tricarboxylic acid cycle flux in peroxisome prolifera-tor-activated receptor gamma coactivator-1a (PGC-1a)-deficient mice. J. Biol. Chem. 281, 19000-19008
45. Berthon, P., Van der Veer, M., Denis, C., and Freyssenet, D. (1997) L-Car-nitine stimulation of mitochondrial oxidative phosphorylation rate in isolated rat skeletal muscle mitochondria. Comp. Biochem. Physiol. A Physiol. 117, 141-145
46. Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., Spiegelman, B., and Montminy, M. (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413, 179-183
47. Defer, N, Best-Belpomme, M., and Hanoune, J. (2000) Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am. J. Physiol. Renal Physiol. 279, F400-F416
48. Servillo, G., Della Fazia, M. A., and Sassone-Corsi, P. (2002) Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM.Exp. Cell Res. 275, 143-154
49. Minnaard, R., Schrauwen, P., Schaart, G., and Hesselink, M. K. (2006) UCP3 in muscle wasting, a role in modulating lipotoxicity? FEBSLett. 580, 5172-5176
50. Anghel, S.I., and Wahli, W. (2007) A kingdom for PPARy. Cell Res. 17, 486-511
51. Nedergaard, J., Petrovic, N, Lindgren, E. M., Jacobsson, A., and Cannon, B. (2005) PPAR7 in the control of brown adipocyte differentiation. Biochim. Biophys. Acta 1740, 293-304
52. 15N-labeled arginine. Biochem. J. 388, 419-425
53. Anderson, R. M., and Weindruch, R. (2010) Metabolic reprogramming, caloric restriction and aging. Trends Endocrinol. Metab. 21, 134-141
54. Bevilacqua, L., Ramsey, J. J., Hagopian, K., Weindruch, R., and Harper, M. E. (2005) Long-term caloric restriction increases UCP3 content but decreases proton leak and reactive oxygen species production in rat skeletal muscle mitochondria. Am. J. Physiol. Endocrinol. Metab. 289, E429-E438
55. Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., Kim, M. K., Beaven, M. A., Burgin, A. B., Manganiello, V., and Chung, J. H. (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421-433
56. Ringseis, R., Mooren, F.-C, Keller, J., Couturier, A., Wen, G., Hirche, F., Stangl, G. I., Eder, K., and Krüger, K. (2011) Regular endurance exercise improves the diminished hepatic carnitine status in mice fed a high-fat diet. Mol. Nutr. Food Res. 55, S193-S202
57. Omori, K., and Kotera, J. (2007) Overview of PDEs and their regulation. CircRes. 100, 309-327
58. Dighe, R. R., Rojas, F. J., Birnbaumer, L., andGarber, A. J. (1984) Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus. J. Clin. Investig. 73, 1013-1023
59. Hardy, A. B., Serino, A. S., Wijesekara, N, Chimienti, F., and Wheeler, M. B. (2011) Regulation of glucagon secretion by zinc: lessons from the/3-cells-specific Znt8 knockout model. Diabetes Obes. Metab. 13, (Suppl. 1) 112-117
60. Pipeleers, D.G., Schuit, F. C, VanSchravendijk, C.F., andVandeWinkel, M. (1985) Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 117, 817-823
61. Sun, Z., and Lazar, M. A. (2013) Dissociating fatty liver and diabetes. Trends Endocrinol. Metab. 24, 4-12